Skip to content

Aberrant receptor expression in thyroid tissue: A role in the pathogenesis of multinodular goiter? A pilot study

Aberrant receptor expression in thyroid tissue: A role in the pathogenesis of multinodular goiter? A pilot study - Aberrant receptor expression in thyroid tissue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40001
Enrollment
15
Registered
2012-10-09
Start date
2012-12-20
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Toxic) Multinodular Goiter

Interventions

no intervention

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Informed consent form signed * Age 18 years and over * Multinodular goiter, confirmed with thyroid ultrasound * Subclinical hyperthyroidism, defined as TSH

Exclusion criteria

Exclusion criteria: * Current use of antithyroid drugs * Treatment with radioactive iodine in history * Pregnancy. This condition may lead to subtle enlargement of the thyroid gland, secondary to iodine deficiency. All premenopausal female participants will undergo a *-hCG-urine test before inclusion. * Born and raised in iodine deficient areas, defined as the green and dark green fields in Figure 3 (protocol, p 13) . * Any medication known to interfere with thyroid hormone metabolism or with the study medication, like amiodarone, beta blockers, neuroleptics, corticosteroids including inhalation steroids, antihistaminics * Any condition that the investigator feels would interfere with trial participation or evaluation of results

Design outcomes

Primary

MeasureTime frame
Endpoint The % increase in total T4, T3 and Free T4, defined as: ([T4/T3/FT4 max * T4/T3/FT4 at baseline]/ T4/T3/FT4 at baseline) x 100%

Secondary

MeasureTime frame
none reported

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)